Physician’s Profile

1
Top Doctor: 
1

Israel Deutsch, MD

Department of Radiation Oncology
Introduction:

Israel Deutsch, M.D., is Assistant Professor of Radiation Oncology at New York-Presbyterian/Columbia University Medical Center. Dr. Deutsch cares for patients with all types of cancer, with a special interest in Prostate, Gynecologic, and Head & Neck cancers. He is Director of Brachytherapy Services in the Department of Radiation Oncology. Dr. Deutsch is a respected researcher with numerous peer-reviewed contributions to medical literature and has edited many book chapters in his areas of expertise. He is a member of the Review Committee on Continuing Medical Education at Columbia University Medical Center. Dr. Deutsch received his medical degree from Albert Einstein College of Medicine. He then received transitional year training during an internship at New York Hospital Queens, after which he completed his radiation oncology residency at SUNY Downstate Medical Center. Dr. Deutsch then furthered his training with a fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center.

In collaboration with several clinical and basic science colleagues, he is conducting a number of clinical and translational studies. Dr. Deutsch sits on the Internal Review Board (IRB) for Clinical Trials and is also a member of the Children’s Oncology Group (COG) as Investigator representing the Department of Radiation Oncology.

Dr. Deutsch is very involved in residency education and serves as Associate Director of the Radiation Oncology Residency Program at New York Presbyterian/Columbia University Medical Center.

Board Certificates
Radiation Oncology
Areas of Expertise:
  • Testicular Cancer
  • Prostate Cancer
  • Kidney & Adrenal Cancer
  • Gynecologic Cancers
  • Bladder Cancer
  • Melanoma
  • Radiation Oncology
  • Head and Neck Cancers
  • Brachytherapy
  • Kidney Cancer
  • Adrenal Cancer
Publications:
Gondi V, Deutsch I, Mansukhani M, O’Toole KM, Shah JN, Schiff PB, Katz AE, Benson MC, Goluboff ET, Ennis RD. Intermediate-Risk Localized Prostate Cancer in the PSA Era: Radiotherapeutic Alternatives. Urology, 2007 March; Vol 69, Issue 3, pp 541-6
Bansal S, Buck AM, Herzog TJ, Deutsch I, Burke WM, Wright JD. Stage IIIA Endometrial Carcinoma: Outcomes and Predictors of Survival. Obstetrics and Gynecology, 2009 July; Vol 114, Issue 1, pp 100-5
Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD. Primary Therapy for Early Stage Cervical Cancer: Radical Hysterectomy versus Radiation. American Journal of Obstetrics and gynecology, 2009 November; Vol 201, Issue 5, pp 485 e1-9
Wright JD, Nathavithrana R, Lewin SN, Sun X, Deutsch I, Burke WM, Herzog TJ. Fertility Conserving Surgery for Young Women with Stage IA1 Cervical Cancer: Safety and Access. Obstetrics and Gynecology, 2010 March; Vol 115, Issue 3, pp 585-90
Wright JD, St Clair CM, Deutsch I, Burke WM, Gorrochurn P, Sun X, Herzog TJ. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma. Cancer. 2010 May 15;116(10):2486-92 Bansal S, Lewin SN, Burke WM, Deutsch I, Sun X, Herzog TJ, Wright JD. Sarcoma of the cervix: natural history and outcomes. Gynecol Oncol. 2010 Aug 1;118(2):134-8